Teva Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Teva Pharmaceuticals

TEVA 20.84

+1.7%

9:53 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: flatsville who wrote (277)	2/15/2001 9:32:26 AM
From: Dorine Essey	Read Replies (1) of 340

DJ Teva/Outlook -3: 4Q '00 Exceeded Mkt Forecasts TEVA -------------------------------------------------------------------------------- DJ Teva/Outlook -3: 4Q '00 Exceeded Mkt Forecasts 15 Feb 05:49 Teva shares had rallied throughout the week in anticipation of good fourth-quarter results. Shani Kogan, an analyst at Nessuah Zannex Securities in Tel Aviv, said the quarter's results had exceeded those expectations. "The results surprised everybody on the positive side. You also have to remember that there was negative sentiment in the month-and-a-half before and the price fell from $70 to $50," said Kogan, who has a $70 target price on the shares. Kogan said it was too early to assess the impact of an agreement Teva announced Wednesday under which its joint-venture partner Aventis Pharmaceuticals Inc. (AVE) agreed to make Teva Marion Partners a wholly owned unit of Teva. Aventis will continue to distribute Teva's key Copaxone multiple-sclerosis drug in North America. -By Amy Teibel, Dow Jones Newswires; +972-2-537-6985; amy.teibel@dowjones.com (David Rosenberg also contributed to this story.) -0- 15/02/01 10-49G (END) DOW JONES NEWS 02-15-01 05:49 AM

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next